{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c"
}

{
"status":1,
"data":
  [
   {"id":"1","weight_band":"less than 3kg"},
   {"id":"2","weight_band":"3kg -5.9kg"},
   {"id":"3","weight_band":"6kg - 9.9kg"}, 
   {"id":"4","weight_band":"10kg -13.9kg"}, 
   {"id":"5","weight_band":"14kg -19.9kg"},
   {"id":"6","weight_band":"20kg - 24.9kg"},
   {"id":"7","weight_band":"25kg -29.9kg"},
   {"id":"8","weight_band":"Adult (>=30kg)"}
  ] 
}

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c",
  "weight": 2 
}

{
 "status":1,
  "id":"2",
  "weight":"3kg - 5.9kg"
}

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c"
}

Sample Response:

{
"status": 1, 
"data": 
 [
  { "id": "1", "title": "< 1 year" }, 
  { "id": "2", "title": "1 to 6 years" }, 
  { "id": "3", "title": "6 to 7 years" }, 
  { "id": "4", "title": "7 to 8 years" }, 
  { "id": "5", "title": "9 to 10 years" }, 
  { "id": "6", "title": "Adolescent" } 
 ] 
}

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c", 
 "weight": 1, 
 "age": 2, 
 "new_patient_failing_patient": 1, 
 "on_tb_treatment": 1 
}

{
 "status":1,
 "0":
  [
   {
   "regimen_id":"1",
   "0":"1",
   "regimen":"AZT + 3TC + DTG",
   "1":"AZT + 3TC + DTG",
   "weight":"1",
   "2":"1",
   "regimen_weight_group":"1",
   "3":"1"
   },
   {
   "regimen_id":"16",
   "0":"16",
   "regimen":"AZT + 3TC + RAL",
   "1":"AZT + 3TC + RAL",
   "weight":"1",
   "2":"1",
   "regimen_weight_group":"1",
   "3":"1"
   }
  ],
 "1":
   [
    { 
    "regimen_id":"2",
    "0":"2",
    "regimen":"AZT + 3TC + LPV/r",
    "1":"AZT + 3TC + LPV/r",
    "weight":"1",
    "2":"1",
    "regimen_weight_group":"1",
    "3":"1"
    }
   ],
 "2":
    [
     { 
     "regimen_id":"3",
     "0":"3",
     "regimen":"AZT + 3TC + NVP",
     "1":"AZT + 3TC + NVP",
     "weight":"1",
     "2":"1",
     "regimen_weight_group":"1",
     "3":"1"
     }
   ],
 "3":
   [
    {
     "regimen_id":"4",
     "0":"4",
     "regimen":"AZT + 3TC + LPV/r",
     "1":"AZT + 3TC + LPV/r",
     "weight":"1",
     "2":"1",
     "regimen_weight_group":"1",
     "3":"1"
    }
   ]
 }

Sample Payload to get Paediatrics ART Dosage:

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c", 
 "weight": 2, 
 "regimen": 1 
}

{ 
  "status":1, 
  "data": 
   [ 
    { 
     "drug":"DTG",
     "dose":"0.5 OD",
     "weight_band":"3kg - 5.9kg",
     "drug_instruction":"Dolutegravir (DTG) 10mg is a dispersible, scored tablet (a tablet to dissolve in liquid and can be split into two halves each of 5mg pDTG) to take by mouth in combination with other ARVs. It can be used in children who are >1 month of age and weigh \u22653kg.  Pediatric DTG 10mg dispersible, scored tablets (pDTG) can be used until 20kg, when children can switch to DTG 50mg film-coated tablets if they can swallow tablets whole. If they are unable to swallow the adult 50mg film-coated tablet whole, 3 (30mg) of the pDTG 10mg DT may be used instead. It is usually taken once a day with or without food. Take dolutegravir at around the same time(s) every day. Do not take more or less than prescribed by your doctor.\r\nAdd the appropriate dose for weight of pDTG to clean water, stir until the tablet(s) dissolves, and administer to the child. The child should drink all the water immediately or within a maximum of 30 minutes.\r\nIf dispersing between 0.5 or 1.5 DTG 10 mg tablets, 5 mL (1 teaspoon) of clean water should be used. When dispersing 2 or more tablets, 10 mL (2 teaspoons) of water should be used. If any medicine remains in the glass, add a little more water to the glass and give to your child. Repeat this step until no medicine remains in the cup.\r\npDTG can be dispersed and administered in the same solution of clean water as ABC/3TC 120/60 mg dispersible tablets. When dispersing both products together, use 10-20 mL (2-4 teaspoons) of clean water and ensure both medicines are properly dissolved before administering. If the tablets do not dissolve completely (i.e., they lump together), stir and slowly add a small amount of extra water until the tablets fully dissolve. \r\npDTG is recommended to be mixed with clean water. However, if a child is unable to take pDTG with water, it is reasonable to mix pDTG with other liquids or foods such as milk, juice, yoghurt, or porridge. Follow the same small volume recommendations, if other liquids are used, to ensure the child takes the full dose of medicine.\r\n",
     "strength":"10mg",
     "has_image":"1"
    }
   ]
 }

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c"
}

Sample Payload to get the list of regimens:

{ 
  "status":1,
  "data":
    [
      {
        "id":"1",
        "regimen":"Cotrimoxazole (CTX) Preventive Therapy"
      },
      {
        "id":"2",
        "regimen":"Isoniazid (INH) TB Preventive Therapy"
      },
      {
        "id":"3",
        "regimen":"3HP TB Preventive Therapy"
      }
    ]
}

Sample Payload to get the weight bands of patient:

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c", 
 "regimen": 2 
}

{ 
  "status":1,
   "data":
   [
    {
     "id":"1",
     "oi_weight":"Below 6 months or < 5 kg "
    },
   {
     "id":"2",
     "oi_weight":"6 months-5 years or 5-15 kg "
   },
   {
     "id":"3",
     "oi_weight":" 6-14 years or 15-30 kg"
   },
   {
    "id":"4",
     "oi_weight":">= 14 years or >30 kg"
   }
 ]  
}

Sample Payload to get the dosage:

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c", 
 "weight": 1 
}

{ 
  "status":1,
  "regimen":"Cotrimoxazole (CTX) Preventive Therapy",
  "oi_weight":"6 months-5 years or 5-15 kg ",
  "no_of_tablets":"2",
  "dosage":"240mg",
  "frequency":"daily",
  "drug_instruction":"Cotrimoxazole should be administered to HIV exposed infants from 6 weeks of age and continue until infection is excluded by an age-appropriate HIV test 6 weeks after complete cessation of breast feeding. The appropriate dose should be given orally to the child based on the age or bodyweight with plenty of water.    HIV positive infants, children and adolescents should also have cotrimoxazole preventive therapy initiated irrespective of clinical or immune conditions. Priority should be given to all children younger than 5 years old regardless of CD4+ cell count or clinical stage, and children with severe or advanced HIV clinical disease (WHO clinical stage 3 or 4) and/or CD4+ cell count \u2264500 cells/mm3"  
}

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c"
}

{ 
  "status":1,
  "data":
    [
     {
     "id":"1",
     "arv_weight":"< 2.5kg"
     },
     {
     "id":"2",
     "arv_weight":">= 2.5kg"
     }
   ]  
}

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c",
 "id": 1 
}

{ 
  "status":1,
  "id":"1",
  "arv_weight":"< 2.5kg"  
}

Sample Payload to get the age range of patients:

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c" 
}

{ 
  "status":1,
  "data":
    [
     {
      "id":"1",
      "arv_age":"0 - 6 Weeks"
     },
     {
      "id":"2",
      "arv_age":"6-12 weeks** only for High risk"
     }
   ]  
}

Sample Payload to get the age range of patients:

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c", 
 "id": 1 
}

{ 
  "status":1,
  "id":"1",
  "arv_age":"0 - 6 Weeks"  
}

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c", 
 "weight": 1, 
 "age": 2, 
 "option_a": 1, 
 "option_b": 2, 
 "option_c": 1, 
"option_d": 1 
}

{ 
 "status":1,
  "risk_type":"1",
  "data":
    [
     {
      "id":"1",
      "regimen":"Nevirapine (NVP) 50mg/5ml"
     }
   ]  
}

{ 
 "jwt": "eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzdWIiOiIxMjM0NTY3ODkwIiwibmFtZSI6IkpvaG4gRG9lIiwiaWF0IjoxNTE2MjM5MDIyfQ.SflKxwRJSMeKKF2QT4fwpMeJf36POk6yJV_adQssw5c", 
 "weight": 2, 
 "age": 1, 
 "risk_type": 1,  
 "regimen": 1 
}

{ 
  "status":1,
  "data":
    [
     {
      "drug":"NVP",
      "dose":"10mg(1ml) once daily",
      "route":"Oral",
      "duration":"12 Weeks",
      "drug_instruction":"Nevirapine 50mg/5ml comes as a suspension and should commence as a monotherapy within 72hours of birth for HIV exposed infants at low risk. Infants at low risk of acquiring HIV infection from their mothers should receive 6 weeks of daily NVP prophylaxis. Nevirapine suspension should be shaken gently prior to administration. The bottle cap should be removed and safely kept. Use the oral dosing syringe supplied with the pack to measure the dose accurately. It is important to administer the entire measured dose of suspension as prescribed. The syringe should be put into the child's mouth, placing the tip of the syringe against the inside of the child's cheek. The plunger should be pushed in slowly, allowing time to swallow. It should not be pushed too hard, and the liquid not squirted into the back of the child's throat to avoid choking. \r\nThe syringe should be washed thoroughly in clean water and let dried completely before using it again, and the bottle tightly closed with the cap.\r\n"},{"drug":"AZT","dose":"10mg (1ml) two times (12hourly) daily","route":"Oral","duration":"12 Weeks","drug_instruction":"Zidovudine oral solution is a colorless to pale yellow strawberry flavored suspension to be administered to high-risk infants in combination with Nevirapine suspension as a dual prophylaxis. All infants born to mothers with HIV who are at high risk of acquiring HIV should receive dual prophylaxis with daily AZT and NVP for the first 12 weeks of life. High-risk infants are defined as those born to women with established HIV infection who have at least one of the following: \r\n\u2022\tHave received < four weeks of ART at the time of delivery \r\n\u2022\tHave VL >1000 copies/ml during the four weeks before delivery, if VL available \r\n\u2022\tHave incident HIV infection during pregnancy or breastfeeding\r\n\u2022\tAre identified for the first time during the postpartum period, with or without a negative HIV test prenatally\r\nZidovudine suspension should be shaken gently prior to administration. The bottle cap should be removed and safely kept. Use the oral dosing syringe supplied with the pack to measure the dose accurately. It is important to administer the entire measured dose of suspension as prescribed. The syringe should be put into the child's mouth, placing the tip of the syringe against the inside of the child's cheek. The plunger should be pushed in slowly, allowing time to swallow. It should not be pushed too hard, and the liquid not squirted into the back of the child's throat to avoid choking. \r\nThe syringe should be washed thoroughly in clean water and let dried completely before using it again, and the bottle tightly closed with the cap. Zidovudine oral solution is associated with hematologic toxicity including neutropenia and severe anemia.\r\n"
     }
   ]  
}